Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Benzinga

This Is What Whales Are Betting On Uber Technologies

Someone with a lot of money to spend has taken a bullish stance on Uber Technologies (NYSE:UBER). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Stocks That Hit 52-Week Lows On Thursday

During Thursday's session, 97 companies made new 52-week lows.

Benzinga

Rivian Heads In The Right Direction: Anaysts Lower Price Targets, Remain Cautiously Optimistic

Electric vehicle Rivian Automotive (NASDAQ: RIVN) recently shared updates on production on the heels of its third-quarter financial results.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Updated 2024 Presidential Election Betting Odds: Where Do Trump, Biden, DeSantis Rank?

The 2022 midterms may have had a large impact on the betting odds for the next president of the United States. The Nov. 8 election decides control of the U.S. House of Representatives, the U.S. Senate and gubernatorial races across the country.

Benzinga

Cathie Wood Swoops In On Weak Tesla: Expect A Bullish Break From This Pattern

Tesla Inc. (NASDAQ: TSLA) opened about 7% higher on Thursday after plunging the same amount on Wednesday, to reach a new two-year low of $177.59.

Benzinga

15M+ Followers, A Love For Axie Infinity And A Knack For Charity: Meet Osito Lima, The Gaming Influencer This World Needed

By Javier Hasse and Franca Quarneti via El Planteo

Benzinga

Zoned Properties Q3 Revenue Grows 59% YoY, Here Are The Details

Zoned Properties, Inc. (OTCQB: ZDPY) Q3 2022 revenues were $614,988, an increase of 58.8% compared to $387,365 in Q3 2021. Net loss was $77,328 compared to a net loss of $95,495 in Q3 2021.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Dow Jumps Over 700 Points; US Inflation Rate Falls In October

U.S. stocks traded sharply higher this morning , following the release of inflation data on Thursday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022

Upgrades

Benzinga

Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results late Wednesday for the third quarter of 2022 and raised the mid-point of 2022 total revenue guidance.

Benzinga

With Bitcoin, Ether And Altcoins Drowning In A Sea Of Blood, Can Investors Hope To Catch A Falling Knife?

The cryptocurrency market continued its downward trajectory on Thursday morning, reeling under the implications of a failed deal between cryptocurrency exchange Binance and its rival FTX, with prices of major digital assets, including altcoins, trading at levels not seen

Benzinga

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11

Bloomberg

Benzinga

October Inflation Cools To 7.7%, Stocks Sprint Higher: What You Need To Know

The SPDR S&P 500 (NYSE: SPY) is moving higher Thursday morning after the Labor Department reported a 7.7% year-over-year increase in the consumer price index for October.

Benzinga

Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Lowell Farms Announces Unaudited Q3 Financial And Operational Results Beneath Expectations

Lowell Farms Inc. (CSE: LOWL; OTCQX: LOWLF), a California-born innovator in cannabis cultivation, announces unaudited revenue and operating results for the third quarter ended September 30, 2022.

Benzinga

Schwazze Announces Record Quarterly Revenue And Adjusted EBITDA In Q3 Report

Medicine Man Technologies Inc. operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) announced its financial results on Wednesday for the third quarter that ended September 30, 2022.

Benzinga

Ayr Wellness Q3 Revenue Grows 24.4% YoY To $119.6M

Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) reported Thursday financial results for the third quarter ended September 30, 2022, with revenue of $119.6 million, up by 24.4% from $96.2 million in the same period of 2021.

Benzinga

Around $5 Million Bet On This Financial Services Stock? Check Out 4 Stocks Insiders Are Buying

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

NewLake Capital Partners Announces Q3 Revenue Totaled $12.1M, 50% YoY Increase

NewLake Capital Partners, Inc. (OTCQX: NLCP) a leading provider of real estate capital to licensed cannabis operators, announced its financial results for the third quarter ended September 30, 2022.

Benzinga

Trulieve Q3 Revenue Grows 34% YoY, What About Adjusted EBITDA?

Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX: TCNNF) released results for the quarter ended September 30, 2022, revealing revenue of $301 million, an increase of 34% compared to $224 million in the same period of 2021.

Benzinga

Tesla Bull Yanks Off EV Maker From Wedbush's 'Best Ideas' List Amid Elon Musk's 'Twitter Antics'

Tesla Inc.

Benzinga

Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.

Benzinga

Motorola Solutions, Domino's Pizza And 2 Other Stocks Insiders Are Selling

The Nasdaq Composite dropped over 250 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Nasdaq, S&P 500 Futures Jump As October Inflation Cools Off — Tesla, Rivian, Apple, AstraZeneca In Focus

The U.S.

Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday

Gainers

1 … 81 82 83 84

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.